Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04538612
Other study ID # 69HCL18_0217
Secondary ID 2019-A00094-53
Status Completed
Phase N/A
First received
Last updated
Start date January 28, 2020
Est. completion date July 10, 2020

Study information

Verified date April 2021
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To estimate peripheral perfusion in shock state, international guidelines recommend the use of capillary refill time, and practitioners currently evaluates it at bedside. However its measurement is not standardized, what should explain the large observer variability reported in different studies. Hence, a device providing a standardized evaluation seems to be helpful. The aim of the study is to evaluate diagnostic performance of such a device recently developped (DiCART TM), in healthy volunteers experiencing vascular occlusion tests to induce impaired perfusion.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date July 10, 2020
Est. primary completion date July 10, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Healthy volunteers - Age > 18 years old - Informed consent to participate Exclusion Criteria: - Vascular disease - Diabetes mellitus - Dermatosis - Cutaneous lesion on a measurement site - Anemia - Pregnancy - Cardiovascular chronic treatment - Non affiliation to a social security regime - Involvement in other interventional study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
measure capillary refill time
Each time, capillary refill time will be evaluated three times consecutively by clinical method applying a firm pressure with the finger during 15s, then brutally releasing it, and estimating time of skin recoloration with a chronometer and by DiCART TM device Three vascular occlusion tests will be successively performed with a cuff during less than 10 minutes: Arterial vascular occlusion test (50mmHg above systolic arterial pressure of the healthy volunteers), Veinous vascular occlusion test (30mmHg), Control test without vascular occlusion test. Capillary refill time measurements will be repeated just before, during and just after vascular occlusion tests. Randomization determine the order of the vascular occlusion tests. Investigators performing capillary refill time evaluation will be blinded from it. Vascular occlusion tests will be alternatively performed by one and the other limb. The whole protocol will be performed at the upper and then at the lower limb.

Locations

Country Name City State
France Hospital Louis Pradel Bron

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Capillary refill time on the thenar eminence evaluated with DiCART TM device. Diagnostic performance of DiCART TM device to detect a capillary refill time variation on the thenar eminence induced by a vascular occlusion test on the arm.
DiCART TM measurement is fully automatized, and may be separated in three consecutive step :
An automatized cutaneous compression
A video acquisition of cutaneous recoloration
Data interpretation The investigators will compute Receptor Operative Characteristics curves with area under the curve, and will determine best threshold and grey zone to evaluate diagnostic performance of DiCART TM device to detect impaired perfusion.
180 minutes
Secondary Capillary refill time evaluated on the knee with DiCART TM device Diagnostic performance of DiCART TM device to detect a capillary refill time variation on the knee induced by a vascular occlusion test on the leg
DiCART TM measurement is fully automatized, and may be separated in three consecutive step :
An automatized cutaneous compression
A video acquisition of cutaneous recoloration
Data interpretation The investigators will compute Receptor Operative Characteristics curves with area under the curve, and will determine best threshold and grey zone to evaluate diagnostic performance of DiCART TM device to detect impaired perfusion.
180 minutes
Secondary Intra -observer variability of capillary refill time measurement with DiCART TM device by performing repetitive measurements by two different investigators. Two different investigators will realize 5 measurements of capillary refill time with DiCART TM device and standard clinical method in physiological conditions in two different sites (knee and thenar eminence). We will compute least significant change and standard deviation/mean ratio to evaluate observer variability. 180 minutes
Secondary Intra -observer variability of capillary refill time measurement with clinical method by performing repetitive measurements by two different investigators. Two different investigators will realize 5 measurements of capillary refill time with DiCART TM device and standard clinical method in physiological conditions in two different sites (knee and thenar eminence). We will compute least significant change and standard deviation/mean ratio to evaluate observer variability. 180 minutes
Secondary Inter-observer variability of capillary refill time measurement with DiCART TM device by performing repetitive measurements by two different investigators. Two different investigators will realize 5 measurements of capillary refill time with DiCART TM device and standard clinical method in physiological conditions in two different sites (knee and thenar eminence). We will compute least significant change and standard deviation/mean ratio to evaluate observer variability. 180 minutes
Secondary Inter-observer variability of capillary refill time measurement with clinical method by performing repetitive measurements by two different investigators. Two different investigators will realize 5 measurements of capillary refill time with DiCART TM device and standard clinical method in physiological conditions in two different sites (knee and thenar eminence). We will compute least significant change and standard deviation/mean ratio to evaluate observer variability. 180 minutes
Secondary Capillary refill time variation induced by vascular occlusion test on the knee with DiCART TM device Standard clinical measurement is realized by applying a firm pressure with the finger during 15s and by brutally releasing it. Then, skin recoloration is evaluated visually with a chronometer. 180 minutes
Secondary Capillary refill time variation induced by vascular occlusion test on the knee with standard clinical method Standard clinical measurement is realized by applying a firm pressure with the finger during 15s and by brutally releasing it. Then, skin recoloration is evaluated visually with a chronometer. 180 minutes
Secondary Capillary refill time variation induced by vascular occlusion test on the thenar eminence with DiCART TM device . Standard clinical measurement is realized by applying a firm pressure with the finger during 15s and by brutally releasing it. Then, skin recoloration is evaluated visually with a chronometer. 180 minutes
Secondary Capillary refill time variation induced by vascular occlusion test on the thenar eminence with standard clinical method. Standard clinical measurement is realized by applying a firm pressure with the finger during 15s and by brutally releasing it. Then, skin recoloration is evaluated visually with a chronometer. 180 minutes
Secondary Capillary refill time measured by mathematical algorithms After the experimental phase, the investigators will develop mathematical algorithms to optimize video data interpretation. 180 minutes
Secondary number of patients with cutaneous lesions To evaluate the safety of DiCART TM device 180 minutes
Secondary Pain evaluation assessed by numeric rating scale Pain scale (minimum 1 to maximum 10), 1=No pain,10=Unbearable pain 180 minutes
See also
  Status Clinical Trial Phase
Terminated NCT04366310 - Capillary Refill Index With Rewarming
Completed NCT02394366 - Topical Salve for Skin Oxygenation and Blood Flow Phase 2
Completed NCT03078712 - Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study N/A
Completed NCT04040478 - Transcutaneous Monitoring of Oxygen and Carbon Dioxide in Surgical Patients
Recruiting NCT03762005 - Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock N/A
Completed NCT02771002 - Assessment of Peripheral Perfusion in the Critically Ill Patient N/A
Completed NCT03845361 - Radial Artery Cannulation and Perfusion Index N/A
Completed NCT04688203 - Effects Magnesium Sulfate and Labetalol Infusion on Peripheral Perfusion and Pain in Nasal Surgeries Phase 1/Phase 2
Recruiting NCT04043481 - Modified Allen's Test and Peripheral Perfusion Index
Completed NCT03395483 - Peripheral and Mesenteric Perfusion in Elective Surgical Patients